Joel Krasnow M.D.

Joel Krasnow MD MBA is an experienced professional in the pharmaceutical industry, currently serving as Vice President of Clinical Development at Eisai Pharmaceuticals since 2011, overseeing all clinical development projects, including a pediatric program for Aciphex. Prior roles include Executive Director at Eisai, where responsibility encompassed clinical programs in immunology and gastroenterology, and Senior Director at Roche Pharmaceuticals, leading clinical data analysis for Tociluzimab, which achieved global product approvals. Previous positions also include Senior Medical Director at Novartis Pharmaceuticals and Medical Director at Pfizer, with extensive experience in strategic development, clinical program leadership, and healthcare consulting. Joel Krasnow holds an MD from McGill University and an MBA from the University of Pittsburgh Katz Graduate School of Business.